MINI FUTURE LONG - QUEST DIAGNOSTICS | Real-time Bid/Ask 13:04:12 23/05/2024 BST | ||
| 2.55 EUR / 2.6 EUR | +1.38% |
|
| Current month | +8.09% | ||
| 1 month | +58.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 2.54 | 0.00% |
| 22/05/24 | 2.54 | -5.58% |
| 21/05/24 | 2.69 | -1.82% |
| 20/05/24 | 2.74 | -1.08% |
| 17/05/24 | 2.77 | +6.13% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 08:24 am
More quotesStatic data
| Product type | Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME73JL |
| ISIN | DE000ME73JL7 |
| Date issued | 17/01/2024 |
| Strike | 114.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.22 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.86 € |
|---|---|
| Lowest since issue | 0.92 € |
| Spread | 0.05 € |
| Spread % | 1.92% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.9
USD
Average target price
146.8
USD
Spread / Average Target
+3.48%
- Stock Market
- Certificates
- Certificat
